BOSTON, MA—The Kansas City Cardiomyopathy Questionnaire (KCCQ) has been integrated into numerous heart failure (HF) and transcatheter device trials to provide insights into the effects of various ...

Secondary outcome measures include the device’s technical success and quality of life (QoL) changes between six months and ...